Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0MJ1L
|
|||
| Former ID |
DNC006239
|
|||
| Drug Name |
2-morpholino-7-phenyl-4H-chromen-4-one
|
|||
| Synonyms |
CHEMBL95309
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H17NO3
|
|||
| Canonical SMILES |
C1COCCN1C2=CC(=O)C3=C(O2)C=C(C=C3)C4=CC=CC=C4
|
|||
| InChI |
1S/C19H17NO3/c21-17-13-19(20-8-10-22-11-9-20)23-18-12-15(6-7-16(17)18)14-4-2-1-3-5-14/h1-7,12-13H,8-11H2
|
|||
| InChIKey |
RWIGISKNQAMRJZ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Phosphodiesterase 3A (PDE3A) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Purine metabolism | |||
| cGMP-PKG signaling pathway | ||||
| cAMP signaling pathway | ||||
| Morphine addiction | ||||
| Reactome | cGMP effects | |||
| G alpha (s) signalling events | ||||
| WikiPathways | miR-targeted genes in muscle cell - TarBase | |||
| miR-targeted genes in lymphocytes - TarBase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Analysis of anti-PDE3 activity of 2-morpholinochromone derivatives reveals multiple mechanisms of anti-platelet activity. Bioorg Med Chem Lett. 2006 Feb 15;16(4):969-73. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.